In vitro and in vivo study of 5-methoxypsoralen skin concentration after topical application, G. Colombo, A. Zucchi, F. Allegra, P. Colombo, F. Zani, P. Santi, Skin Pharmacol. Appl. Skin Physiol., 16 (2), 130-136 (2003)

Skin permeation of 5-methoxypsoralen from topical dosage forms, G. Colombo, M. Artusi, P. Santi, P. Colombo, R. Bettini, A. Zucchi, S. Nicoli, Drug Dev. Ind. Pharm., 29 (2), 247-251 (2003)

Characterization of the permselective properties of rabbit skin during transdermal iontophoresis, S. Nicoli, M. Cappellazzi, P. Colombo, P. Santi, J. Pharm, Sci., 92 (7), 1482-1488 (2003)

Distribution and quantification of polyethylenimine oligodeoxynucleotide complexes in human skin after iotophoretic delivery using confocal scanning laser microscopy, C. Brus, P. Santi, P. Colombo, T. Kissel, J. Control. Release, 84, 171-181 (2002).

Physical and chemical enhancement of transdermal delivery of triptorelin, S. Nicoli, S. Rimondi, P. Colombo, P. Santi, Pharm. Res., 18 (11), 1634-1637 (2001).

Plasma and skin concentration of 5-Methoxypsoralen in psoriatic patients after oral administration, A. Zucchi, E. Raho, B. Marconi, M. Santini, F. Allegra, P. Colombo, R. Bettini, P. Santi, J. Invest. Dermatol., 117, 379-382 (2001).

Design of triptorelin loaded nanospheres for transdermal iontophoretic administration, S. Nicoli, P. Santi, P. Couvreur, G. Couarraze, P. Colombo, E. Fattal, Int. J. Pharm., 214, 31-35 (2001)

Ionized prodrugs of dehydroepiandrosterone for transdermal iontophoretic delivery, S. Laneri, A. Sacchi, E. Abignente di Frassello, E. Luraschi, P. Colombo, P. Santi, Pharm. Res., 16 (12), 1818-1824 (1999)

Distribution of khellin in excised human skin following iontophoresis and passive dermal transport, B. Marconi, F. Mancini, P. Colombo, F. Allegra, F. Giordano, A. Gazzaniga, G. Orecchia, P. Santi, J. Control. Release, 60 (2-3), 261-268 (1999)